We are live on
!
Find out more
KT
Kevin Tang Portfolio holdings
AUM
$783
1-Year Est. Return
75.59%
This Fund
S&P 500
This Quarter
Est. Return
-25.36%
1 Year Est. Return
-75.59%
3 Year Est. Return
-70.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$768K
AUM Growth
-$261K
(-25%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LJPC
1
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $766K | 99.74% |
240,000
| – | – |
|
2
Heron Therapeutics
HRTX
$86.9M
| $2K | 0.26% |
760
| – | – |
|
Similar funds
GM
ALBM
RIA
MVPI
AV
TMC
TAM
AC
Kevin Tang's Q2 2022 Portfolio in Review
As of Q2 2022, Kevin Tang held 2 positions worth $768K, down 25% from $1.03M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 0%. Kevin Tang opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Kevin Tang's ten largest holdings make up 100% of its $768K portfolio in Q2 2022.
- Kevin Tang opened 0 new positions and closed 0 in Q2 2022.
- Kevin Tang's portfolio value fell 25% quarter-over-quarter to $768K.
Based on Kevin Tang's 13F filing for Q2 2022, filed 15 Aug 2022.